Connect your AI

Establishment Labs ESTA 2028

2028 at other companies

Globus MedicalGMED

——

SolventumSOLV

——

MedtronicMDT

——

Other financials

Income statement

Revenue$59.9M+44.7%

Gross profit$42.3M+52.2%

Operating income-$6.5M+61.6%

Net income-$13.4M+35.4%

EPS (diluted)-$0.45+35.7%

Balance sheet

Cash & equivalents$68.1M-1.6%

Total debt$252.7M+12.0%

Total equity$14.8M-61.7%

Total assets$351.0M+5.3%

Cash flow

Operating cash flow-$4.3M+79.2%

CapEx$1.9M+146%

Free cash flow-$6.2M+71.3%

Valuation

Market cap$2.56B+41.4%

Enterprise value$2.75B+38.7%

P/S11.2×+0.5×

Profitability

Gross margin70.1%+3.7pp

Operating margin-12.4%-4.8pp

Net margin-19.1%-7.4pp

FCF margin-18.1%-6.6pp

Returns & leverage

Return on equity-164%-17.8pp

Debt / equity17.1×+11.2×

Current ratio3×-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Establishment Labs's 2028?: Establishment Labs (ESTA) reported 2028 of $1.99M in Q1 2026.
How has Establishment Labs's 2028 changed year-over-year?: Establishment Labs's 2028 decreased by 9.1% year-over-year, from $2.19M to $1.99M.